Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Micrornas and Diabetes Mellitus Type 1 Publisher Pubmed



Bahreini F1, 2 ; Rayzan E3, 4 ; Rezaei N2, 3, 5
Authors

Source: Current Diabetes Reviews Published:2022


Abstract

Type 1 diabetes mellitus is a multifactorial, progressive, autoimmune disease with a strong genetic feature that can affect multiple organs, including the kidney, eyes, and nerves. Early detection of type 1 diabetes can help critically to avoid serious damages to these organs. MicroR-NAs are small RNA molecules that act in post-transcriptional gene regulation by attaching to the complementary sequence in the 3'-untranslated region of their target genes. Alterations in the expression of microRNA coding genes are extensively reported in several diseases, such as type 1 diabetes. Presenting non-invasive biomarkers for early detection of type 1 diabetes by quantifying microRNAs gene expression level can be a significant step in biotechnology and medicine. This review discusses the area of microRNAs dysregulation in type 1 diabetes and affected molecular mechanisms involved in pancreatic islet cell formation and dysregulation in the expression of inflammatory elements as well as pro-inflammatory cytokines. © 2022 Bentham Science Publishers.
Other Related Docs
5. Epigenetics of Autoimmune Diseases, Prognostic Epigenetics (2019)
12. Pancreatic Islet Differentiation of Human Embryonic Stem Cells by Microrna Overexpression, Journal of Tissue Engineering and Regenerative Medicine (2016)
18. Association of Mir-146A Expression and Type 2 Diabetes Mellitus: A Meta-Analysis, International Journal of Molecular and Cellular Medicine (2017)
20. Association of Lin-28A Rs3811464 Variant With Susceptibility to Type 2 Diabetes, Journal of Clinical and Diagnostic Research (2017)